1-8 of 8
Arjen Q Bakker
Close
Sort by
Journal Articles

AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses

Marijn A. Gillissen, Martijn Kedde, Greta de Jong, Gemma Moiset, Etsuko Yasuda, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Koen Wagner, Martino Böhne, Paul J. Hensbergen, Dave Speijer, Pauline M. van Helden, Tim Beaumont, Hergen Spits, Mette D. Hazenberg
Journal: Blood
Blood (2018) 131 (1): 131–143.
https://doi.org/10.1182/blood-2017-02-768762
Published: 2018
Includes: Supplemental data
Journal Articles

Tumor Specific Glycosylated CD43 Is a Novel and Highly Specific Target for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Marijn A. Gillissen, MD, Martijn Kedde, PhD, Greta de Jong, MD, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Marie Jose Kersten, MD PhD, Paul Hensbergen, PhD, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1646.
https://doi.org/10.1182/blood.V128.22.1646.1646
Published: 2016
Journal Articles

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Marijn Aletta Gillissen, MD, Martijn Kedde, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Martino Bohne, Dave Speijer, PhD, Daisy I. Picavet, Jan Stap, Marinus H. J. van Oers, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3146.
https://doi.org/10.1182/blood.V126.23.3146.3146
Published: 2015
Journal Articles

AML Relapse after Rituximab Treatment for Graft-Versus-Host Disease: Crucial Role for B Cells in Graft-Versus-Host and Graft-Versus-Leukemia

Marijn Aletta Gillissen, MD, Sophie E. Levie, Greta de Jong, MD, Etsuko Yasuda, PhD, Arjen Q. Bakker, Pauline M. van Helden, PhD, Douglas M. Jefferson, PhD, Cynthia Huisman, MD PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5473.
https://doi.org/10.1182/blood.V126.23.5473.5473
Published: 2015
Journal Articles

Unique and Potent Tumor Specific Antibodies in Graft Versus Leukemia Responses

Marijn A. Gillissen, MD, Etsuko Yasuda, PhD, Sophie Levie, Arjen Q Bakker, Martijn Kedde, Yvonne B Claassen, Cynthia Huisman, MD PhD, Hergen Spits, PhD, Tim Beaumont, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3826.
https://doi.org/10.1182/blood.V124.21.3826.3826
Published: 2014
Journal Articles

NFAT-controlled expression of GFP permits visualization and isolation of antigen-stimulated primary human T cells

Erik Hooijberg, Arjen Q. Bakker, Janneke J. Ruizendaal, Hergen Spits
Journal: Blood
Blood (2000) 96 (2): 459–466.
https://doi.org/10.1182/blood.V96.2.459
Published: 2000
Journal Articles

Genetic Modification of Human B-Cell Development: B-Cell Development Is Inhibited by the Dominant Negative Helix Loop Helix Factor Id3

Ana C. Jaleco, Alexander P.A. Stegmann, Mirjam H.M. Heemskerk, Franka Couwenberg, Arjen Q. Bakker, Kees Weijer, Hergen Spits
Journal: Blood
Blood (1999) 94 (8): 2637–2646.
https://doi.org/10.1182/blood.V94.8.2637.420k22_2637_2646
Published: 1999
Journal Articles

TCR Gene Rearrangements and Expression of the Pre-T Cell Receptor Complex During Human T-Cell Differentiation

Bianca Blom, Martie C.M. Verschuren, Mirjam H.M. Heemskerk, Arjen Q. Bakker, Ellen J. van Gastel-Mol, Ingrid L.M. Wolvers-Tettero, Jacques J.M. van Dongen, Hergen Spits
Journal: Blood
Blood (1999) 93 (9): 3033–3043.
https://doi.org/10.1182/blood.V93.9.3033
Published: 1999